Aragen’s OEB-5 containment infrastructure (OEL < 1 µg/m³) supports an integrated discovery platform spanning payload chemistry, linker design, bioconjugation, and biological and analytical characterization. With this integrated platform, you can advance ADC candidates from antibody discovery through early candidate evaluation in one coordinated environment—reducing handoffs, accelerating development timelines, and improving decision-making.
Antibody Discovery and Engineering
Bioconjugation Technologies
High-Potency Payload and Linker Expertise
Our platform supports synthesis and handling of ADC payloads and linkers, including:
Payload handling is performed in high-containment environments designed for potent compounds.
ADC Characterization and Analytical Services
High-Containment Infrastructure
ADC discovery is performed in OEB-5 laboratories designed for safe handling of highly potent compounds:
These systems ensure safe, controlled, and contamination-free ADC discovery workflows.
Why Partner with Us for ADC Discovery?
ADC discovery demands specialized expertise, speed, and rigorous safety to handle highly potent compounds. Aragen delivers integrated capabilities to accelerate discovery programs.
Functional and Mechanistic Evaluation
Let’s Advance Your ADC Program
Whether you are exploring novel payloads, optimizing linker systems, or evaluating early ADC constructs, our teams are ready to support your discovery journey. Contact us today.